Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    March 2018
  1. KRANTZ SB
    Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2018 Mar 26. pii: 10.1245/s10434-018-6441.
    PubMed     Text format    


    February 2018
  2. MORENO AC, Haque W, Verma V, Fang P, et al
    Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2018 Feb 26. pii: 10.1245/s10434-018-6399.
    PubMed     Text format     Abstract available


  3. OKADA S, Shimada J, Teramukai S, Kato D, et al
    Risk Stratification According to the Prognostic Nutritional Index for Predicting Postoperative Complications After Lung Cancer Surgery.
    Ann Surg Oncol. 2018 Feb 15. pii: 10.1245/s10434-018-6368.
    PubMed     Text format     Abstract available


  4. CLEMENT-DUCHENE C, Luc A, Casse JM, Vignaud JM, et al
    Survival Impact of Stations of Pathological Lymph Nodes in N2 Non-small Cell Lung Cancer in a French Hospital.
    Ann Surg Oncol. 2018 Feb 14. pii: 10.1245/s10434-018-6373.
    PubMed     Text format     Abstract available


  5. JIN K, Wang K, Zhang H, Pan Y, et al
    Solitary Pulmonary Lesion in Patients with History of Malignancy: Primary Lung Cancer or Metastatic Cancer?
    Ann Surg Oncol. 2018 Feb 7. pii: 10.1245/s10434-018-6360.
    PubMed     Text format     Abstract available


    January 2018
  6. RENAUD S, Seitlinger J, Guerrera F, Reeb J, et al
    Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.
    Ann Surg Oncol. 2018 Jan 23. pii: 10.1245/s10434-018-6347.
    PubMed     Text format     Abstract available


  7. TAKAMORI S, Toyokawa G, Okamoto T, Shimokawa M, et al
    Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Jan 11. pii: 10.1245/s10434-017-6328.
    PubMed     Text format     Abstract available


    November 2017
  8. HENNON M, Sahia R, Yendamuri S, Demmy T, et al
    Video-Assisted Thoracic Surgery for Patients with Advanced-Stage Non-small Cell Lung Cancer: A Reply.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6233.
    PubMed     Text format    


  9. FUNAI K
    Can Vessel Invasion Change the TNM Stage in Non-small Cell Lung Cancer? A Reply.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6246.
    PubMed     Text format    


  10. CAO C, Yan TD, He J
    Video-Assisted Thoracic Surgery for Patients with Advanced Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6232.
    PubMed     Text format    


    August 2017
  11. SEOK Y, Kang HG, Lee SY, Jeong JY, et al
    Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-6002.
    PubMed     Text format     Abstract available


    March 2017
  12. HENNON M, Landreneau RJ
    Role of Segmentectomy in Treatment of Early-Stage Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Mar 1. doi: 10.1245/s10434-017-5787.
    PubMed     Text format     Abstract available


    February 2017
  13. YOUNG KA, Efiong E, Dove JT, Blansfield JA, et al
    External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.
    Ann Surg Oncol. 2017 Feb 6. doi: 10.1245/s10434-017-5795.
    PubMed     Text format     Abstract available


  14. PEZZI TA, Mohamed AS, Fuller CD, Blanchard P, et al
    Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2017 Feb 2. doi: 10.1245/s10434-017-5786.
    PubMed     Text format     Abstract available


    October 2016
  15. NOJIRI T, Hamasaki T, Inoue M, Shintani Y, et al
    Long-Term Impact of Postoperative Complications on Cancer Recurrence Following Lung Cancer Surgery.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  16. SHIMAMATSU S, Okamoto T, Haro A, Kitahara H, et al
    Prognostic Significance of Expression of the Epithelial-Mesenchymal Transition-Related Factor Brachyury in Intrathoracic Lymphatic Spread of Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  17. SAMAYOA AX, Pezzi TA, Pezzi CM, Greer Gay E, et al
    Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  18. KANZAKI R, Naito H, Kise K, Takara K, et al
    PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with Non-small Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  19. ANDTBACKA RH, Ross M, Puzanov I, Milhem M, et al
    Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  20. PATEL D, Townsend AR, Karapetis C, Beeke C, et al
    Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  21. KUSAMURA S, Torres Mesa PA, Cabras A, Baratti D, et al
    The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2016;23:1468-73.
    PubMed     Text format     Abstract available


  22. JUDGE S, Thomas P, Govindarajan V, Sharma P, et al
    Malignant Peritoneal Mesothelioma: Characterization of the Inflammatory Response in the Tumor Microenvironment.
    Ann Surg Oncol. 2016;23:1496-500.
    PubMed     Text format     Abstract available


    April 2016
  23. ZHANG F, Zheng W, Ying L, Wu J, et al
    A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  24. BU S, Wang R, Pan Y, Yu S, et al
    Clinicopathologic Characteristics of Patients with HER2 Insertions in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  25. LIU SR, Qiu B, Yang H, Liang Y, et al
    Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  26. WANG BY, Huang JY, Ko JL, Lin CH, et al
    A Population-Based Cost Analysis of Thoracoscopic Versus Open Lobectomy in Primary Lung Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  27. ANDREOU D, Gilg MM, Gosheger G, Werner M, et al
    Metastatic Potential of Grade I Chondrosarcoma of Bone: Results of a Multi-institutional Study.
    Ann Surg Oncol. 2016;23:120-5.
    PubMed     Text format     Abstract available


    October 2015
  28. PARK HS, Jung M, Shin SJ, Heo SJ, et al
    Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  29. POLANCO PM, Ding Y, Knox JM, Ramalingam L, et al
    Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies.
    Ann Surg Oncol. 2015;22:1673-9.
    PubMed     Text format     Abstract available


  30. MISE Y, Kopetz S, Mehran RJ, Aloia TA, et al
    Is complete liver resection without resection of synchronous lung metastases justified?
    Ann Surg Oncol. 2015;22:1585-92.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: